Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol vs Oxytocin for Blood Loss in Myomectomy
NCT06325501Phase 3Recruiting
- Sponsor
- Cairo University
- Start
- Mar 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of misoprostol in uterine leiomyoma, sponsored by Cairo University. Started Mar 2024; status: recruiting.
02
Drugs
misoprostol
03
Conditions
uterine leiomyoma
Beyond the preview
Go deeper on NCT06325501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06325501.